Surgical and molecular approaches to the sentinel lymph nodes

Annals of Surgical Oncology

Volumn 8, Issue 9 SUPPL., 2001, Pages 31-34

  Essner, R ^a   Kojima, M ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

Dendritic cells; Immunosuppression; Melanoma; Sentinel lymph nodes

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CELL MARKER; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ANTIGEN EXPRESSION; B LYMPHOCYTE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MELANOMA; MOLECULAR BIOLOGY; SENTINEL LYMPH NODE; T LYMPHOCYTE;

ANTIGENS, CD; ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, NEOPLASM; HUMANS; LYMPHATIC METASTASIS; MELANOMA; MEMBRANE GLYCOPROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 0034774780     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Technical details of intraoperative lymphatic mapping for early stage melanoma
2. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer
3. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma. A multicenter trial
4. T-zone histocytes in adenocarcinoma of the lung in relation to postoperative prognosis
5. Langerhans cells and prognosis in patients with gastric carcinoma
6. Immunosuppression by melanoma cells as a factor in the generation of metastatic disease
7. Lymphocytes from lymph nodes at different distances from human melanoma vary in their capacity to inhibit/enhance tumor cell growth in vitro
8. Variations in functional immunocompetence of individual tumor-draining lymph nodes in humans
9. Clinical significance of defective dendritic cell differentiation in cancer
10. Dendritic cells and the control of immunity
11. Functions of CD40 on B cells, dendritic cells, and other cells
12. Standardized probe-directed sentinel node dissection in melanoma
13. Expression of the co-stimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies
14. Human muscle cells express a functional co-stimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions
15. Quantitative alterations in cutaneous Langerhans cells during the evolution of malignant melanoma of the skin
16. Selective modulation of paracortical dendritic cells and T-lymphocytes in breast cancer sentinel lymph nodes
17. Regulation of dendritic cell trafficking: A process that involves the participation of selective chemokines
18. Natural adjuvants: Endogenous activators of dendritic cells
19. Antitumor effect of CD40 ligand: Elicitation of local and systemic antitumor responses by IL-12 and B7
20. Characterization of dendritic cells generated from peripheral blood of patients with malignant melanoma
21. Cytokines as an adjuvant to tumor vaccines: Efficacy of local methods of delivery
22. Antitumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells
23. Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor